ArticleHemaSphere2023
PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?
Open access · goldAbstract read
In one paragraph
Article in HemaSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 5 citations in OpenAlex.
- Article
- Article
- Current Issues and Future Perspectives of Targeted Therapies in Primary Mediastinal Large B-Cell Lymphoma.Journal of clinical medicine · 2025Review
- Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysis.Journal of the National Cancer Center · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
47 authors at 17 institutions in 1 country.
Theodoros P VassilakopoulosDepartment of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Greece.
Alexia PiperidouDepartment of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Greece.
Zois MelliosDepartment of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece.
Evgenia VerigouDepartment of Internal Medicine, Hematology Division, University of Patras, Rion, Greece.
Eirini KatodritouDepartment of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece.
Christina KalpadakisDepartment of Hematology, University of Crete, Iraklion, Greece.
Sotirios G PapageorgiouSecond Department of Internal Medicine, Propaedeutic, Hematology Unit, National and Kapodistrian University of Athens, University General Hospital "Attikon," Greece.
Chrysovalantou ChatzidimitriouDepartment of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Greece.
Vassilios PrassopoulosHygeia Hospital, Athens, Greece.
Marina P SiakantarisDepartment of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Greece.
Hara GiatraDepartment of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece.
Dimitrios KarantanisDepartment of Nuclear Medicine, Iatropolis, Athens, Greece.
Nikolaos PapathanasiouDepartment of Nuclear Medicine, University Hospital of Patras, Rion, Greece.
Loukia LigdiDepartment of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece.
Anastasia KopsaftopoulouDepartment of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Greece.
Theoni LeonidopoulouDepartment of Hematology, Sismanoglion General Hospital, Athens, Greece.
Vasileios XanthopoulosDepartment of Hematology, Hygeia Hospital, Athens, Greece.
Stamatios KarakatsanisThird Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece.
Effimia VrakidouHygeia Hospital, Athens, Greece.
Sophia ChatziioannouDepartment of Nuclear Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Greece.
Dimitrios DrougkasDepartment of Nuclear Medicine and PET/CT, Vioiatriki, Thessaloniki, Greece.
Eleftheria HatzimichaelDepartment of Hematology, University of Ioannina, Greece.
Gabriella GainaruHygeia Hospital, Athens, Greece.
Maria PalassopoulouDepartment of Hematology, University of Thessalia Hospital, Larissa, Greece.
Maria TsirogianniDepartment of Hematology, Saint Savvas Anticancer Hospital, Athens, Greece.
Maria KotsopoulouDepartment of Hematology, Metaxa Anticancer Hospital, Piraeus, Greece.
Gerassimos TsourouflisSecond Department of Surgery, Propedeutic, National and Kapodistrian University of Athens, Laikon General Hospital, Greece.
Evangelia SkouraDepartment of Nuclear Medicine and PET/CT, Vioiatriki, Athens, Greece.
Catherine MaintaDepartment of Nuclear Medicine and PET/CT, Athens Medical Center, Greece.
Evangelos TerposDepartment of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Greece.
Christos PoziopoulosDepartment of Hematology, Metropolitan Hospital, N. Faliron, Athens, Greece.
Theodora TriantafyllouDepartment of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece.
Panayiotis ZikosHaematology Unit, General Hospital of Patras "Agios Andreas," Greece.
Argyro KoumarianouFirst Department of Hematology, Metropolitan General Hospital, Athens, Greece.
Dimitra LiapiDepartment of Hematology, Venizelion Hospital, Iraklion, Crete, Greece.
Vassiliki PappaSecond Department of Internal Medicine, Propaedeutic, Hematology Unit, National and Kapodistrian University of Athens, University General Hospital "Attikon," Greece.
Evgenia VerrouDepartment of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece.
Panayiotis TsirigotisSecond Department of Internal Medicine, Propaedeutic, Hematology Unit, National and Kapodistrian University of Athens, University General Hospital "Attikon," Greece.
Vassiliki LabropoulouDepartment of Internal Medicine, Hematology Division, University of Patras, Rion, Greece.
Helen PapadakiDepartment of Hematology, University of Crete, Iraklion, Greece.
Ioannis DatserisDepartment of Nuclear Medicine and PET/CT, Evangelismos General Hospital, Athens, Greece.
Argiris SymeonidisDepartment of Internal Medicine, Hematology Division, University of Patras, Rion, Greece.
Maria BouzaniDepartment of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece.
Maria BakiriDepartment of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece.
Themis KarmirisDepartment of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece.
Maria K AngelopoulouDepartment of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Greece.
Phivi RondogianniDepartment of Nuclear Medicine and PET/CT, Evangelismos General Hospital, Athens, Greece.
National and Kapodistrian University of Athens · GREvangelismos Hospital · GRHygeia Hospital · GRTheageneio General Hospital · GRUniversity of Patras · GRMetropolitan Hospital · GRUniversity of Crete · GRAgios Andreas Hospital · GRAthens Medical Center · GRGeneral University Hospital of Patras · GRMetaxa Hospital · GRSismanoglio General Hospital · GRSt Savas Hospital · GRThe General Hospital of Heraklion "Venizeleio-Pananio" · GRUniversity General Hospital Attikon · GRUniversity Hospital of Larissa · GRUniversity of Ioannina · GR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.